DEC 10, 2019 2:37 PM PST

Increased Cannabis Use Associated with Depression in U.S.

WRITTEN BY: Kara Marker

More than 700,000 people ages 12 and older responded to a survey assessing cannabis use, depressive status, and perceptions of risk associated with cannabis use. Researchers interested in tying these three factors together to understand more about cannabis use habits analyzed the data and made several significant observations.

First, researchers observed from the data an increasing total number of people using cannabis in the United States between 2005 and 2017, those with depression and without depression combined. However, the number of people using cannabis increased more exponentially in the population of people with depression.

In 2017, cannabis use was twice as common among people with depression compared to those without it. Additionally in 2017, perceptions of risk associated with cannabis use varied in populations with depression and populations without. People with depression were less likely to associate cannabis use with great risk compared to people without depression.

Lastly, researchers observed an increased number of people who reported cannabis use within the past 30 days among people with depression who did not associate regular cannabis use with great risk. This is compared to people with depression who did associate regular cannabis use with great risk.

Do people with depression perceive low risk associated with cannabis use because they believe it will improve their health or mood? Or does a state of depression affect the way people perceive risk associated with cannabis use and other behaviors? Scientists have yet to elucidate the exact relationships that explain the association with depression, cannabis use, and cannabis risk perception, and more research is needed to highlight these solutions.

Depression is a mood disorder characterized by several signs and symptoms that include chronic low moods, irritability, fatigue, and sleep disruption. Depression can occur alongside or as a result of other mood disorders such as postpartum depression, psychotic depression, seasonal affective disorder, and bipolar disorder. The Anxiety and Depression Association of America reports that 322 million people across the globe experience depression, and 6.7 percent of adults in the United States reported experiencing at least one major depressive episode within the last year.

Sources: Addiction, Wiley

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 25, 2020
Cannabis Sciences
JAN 25, 2020
Cannabis Genetics 101
This is an introduction into cannabis genetics including chromosome number, genetic variation leading to expression differences, and genome size....
JAN 25, 2020
Cannabis Sciences
JAN 25, 2020
CBD Alleviates Angelman Syndrome Seizures in Mice Trial
CBD has already been shown to be effective as an anti-anxiety, antipsychotic and anti-epileptic substance. Can it help youth and adults with a rare neurolo...
JAN 25, 2020
Drug Discovery & Development
JAN 25, 2020
Therapeutic To Treat The Detrimental Effects of Marijuana
As U.S. states continue to legalize the use of marijuana, so is the number of American women using cannabis before becoming pregnant and to treat morning s...
JAN 25, 2020
Cannabis Sciences
JAN 25, 2020
Cannabis Linked with PTSD Relief
Data from a new Canadian survey suggest that cannabis use can be beneficial for people with post-traumatic stress disorder (PTSD), a psychiatric disorder t...
JAN 25, 2020
Cannabis Sciences
JAN 25, 2020
USDA Approves First State Hemp Growing Plans
Hemp can be cultivated for use as fiber, building materials, CBD oil and more. This plant and its derivatives were legalized federally under the 2018 Farm...
JAN 25, 2020
Health & Medicine
JAN 25, 2020
Next Big Thing For Cannabis Users: Sublingual Strips?
Aleafia Health signed an agreement with Kinstate, Inc. allowing the company to manufacture, market, and sell Kin Slips and the technology behind these cann...
Loading Comments...